Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Repositori Obert UdL
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Subjects with detectable Saccharomyces cerevisiae in the gut microbiota show deficits in attention and executive function

  • Arnoriaga Rodríguez, María
  • Mayneris Perxachs, Jordi
  • Coll, Claudia
  • Pérez Brocal, Vicente
  • Ricart, Wifredo
  • Moya, Andrés
  • Ramió Torrentà, Lluís
  • Pamplona Gras, Reinald
  • Jové Font, Mariona
  • Portero Otín, Manuel
  • Fernández Real, José Manuel
This work was partially supported by researchgrants FIS (PI15/01934 and PI18/01022) from theInstituto de Salud Carlos III from Spain, SAF2015-65878-R and RTI2018-099200-B-I00 from theMinisterio de Econom ıa y Competitividad, Prome-teo/2018/A/133 from Generalitat Valenciana,Spain, and also by Fondo Europeo de DesarrolloRegional (FEDER) funds, European Commission(FP7, NeuroPain #2013-602891), the Generalitat ofCatalunya (AGAUR, #SGR2017-669, #SGR2017-696, Department of Health SLT002/16/00250;ICREA Academia Award 2015), the Instituto deSalud Carlos III from Spain (RTA, #RD16/0017/0020) and the Fondo Europeo de DesarrolloRegional (No. 01.2.2-LMT-K-718-02-0014); andby Project ThinkGut (EFA345/19), 65% co-fi-nanced by the European Regional DevelopmentFund (ERDF) through the Interreg V-A Spain-France-Andorra programme (POCTEFA 2014-2020). Mar ıa Arnoriaga-Rodr ıguez is funded byInstituto de Salud Calos III, R ıo Hortega (CP19/00190). Jordi Mayneris-Perxachs is funded by theMiguel Servet Program from the Instituto de SaludCarlos III (ISCIII CP18/00009), co-funded by theEuropean Social Fund “Investing in your future”.Mariona Jov e is a professor under the Serra Hunterprogramme (Generalitat de Catalunya).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Presence of Blastocystis in gut microbiota is associated with cognitive traits and decreased executive function

  • Mayneris Perxachs, Jordi
  • Arnoriaga Rodríguez, María
  • Garre Olmo, Josep
  • Puig, Josep
  • Ramos, Rafael
  • Trelis, Maria
  • Burokas, Aurelijus
  • Coll, Claudia
  • Zapata, Cristina
  • Pedraza, Salvador
  • Pérez Brocal, Vicente
  • Ramió Torrentà, Lluís
  • Ricart, Wifredo
  • Moya, Andrés
  • Jové Font, Mariona
  • Sol, Joaquim
  • Portero Otín, Manuel
  • Pamplona Gras, Reinald
  • Maldonado, Rafael
  • Fernández Real, José Manuel
Growing evidence implicates the gut microbiome in cognition. Blastocystis is a common gut single-cell eukaryote parasite frequently detected in humans but its potential involvement in human pathophysiology has been poorly characterized. Here we describe how the presence of Blastocystis in the gut microbiome was associated with deficits in executive function and altered gut bacterial composition in a discovery (n = 114) and replication cohorts (n = 942). We also found that Blastocystis was linked to bacterial functions related to aromatic amino acids metabolism and folate-mediated pyrimidine and one-carbon metabolism. Blastocystis-associated shifts in bacterial functionality translated into the circulating metabolome. Finally, we evaluated the effects of microbiota transplantation. Donor’s Blastocystis subtypes led to altered recipient’s mice cognitive function and prefrontal cortex gene expression. In summary, Blastocystis warrant further consideration as a novel actor in the gut microbiome-brain axis., This study was partially funded by the Catalan Government (AGAUR, #SGR2017-0734, ICREA Academia Award 2021) to J.M.F.-R., Instituto de Salud Carlos III (Madrid, Spain) through the projects PI15/01934, PI18/01022 and PI21/01361 to JMF-R, the project PI20/01090 (Co-funded by European Regional Development Fund “A way to make Europe”) to JM-P, and the project PI20/0155 to MP-O; the grants SAF2015-65878-R from Ministry of Economy and Competitiveness, Prometeo/2018/A/133 from Generalitat Valenciana, Spain and also by Fondo Europeo de Desarrollo Regional (FEDER) funds (“A way to build Europe”), European Commission (FP7), the Catalan Government (AGAUR, #SGR2017-669, ICREA Academia Award 2020 and Ministerio de Ciencia e Innovación PID2020- 120029GB-I00/MICIN/AEI/10.13039/501100011033, and RD21/0009/0019, European Commission-DG Research” (PainFact, H2020-SC1-2019-2-RTD-848099, QSPain Relief, H2020-SC1-2019-2-RTD-848068 to R.M.), the Spanish Instituto de Salud Carlos III (RTA, #RD16/0017/0020) and the European Regional Development Fund (project No. 01.2.2-LMT-K-718-02-0014) under grant agreement with the Research Council of Lithuania (LMTLT). We also acknowledge funding from the Spanish Ministry of Science, Innovation and Universities (RTI2018-099200-B-I00), and the Generalitat of Catalonia (Agency for Management of University and Research Grants (2017SGR696) and Department of Health (SLT002/16/00250)) to RP; María Arnoriaga-Rodríguez is funded by Instituto de Salud Carlos III, Río Hortega (CM19/00190). JM-P is funded by Instituto de Salud Carlos III through the Miguel Servet Program project CP18/00009 (Co-funded by the European Social Fund “Investing in your future”). MJ is a “Serra-Hunter” fellow.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Daidzein modulates cocaine-reinforcing effects and cue-induced cocaine reinstatement in CD-1 male mice

  • Martin, Miquel|||0000-0001-7771-611X
  • Gutiérrez-Martos, Miriam
  • Cabrera, Roberto
  • Langohr, Klaus|||0000-0001-7075-9192
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torre, Rafael de la|||0000-0002-6765-1866
Cocaine addiction is a chronic relapsing disorder that lacks of an effective treatment. Isoflavones are a family of compounds present in different plants and vegetables like soybeans that share a common chemical structure. Previous studies have described that synthetic derivatives from the natural isoflavone daidzin can modulate cocaine addiction, by a mechanism suggested to involve aldehyde-dehydrogenase (ALDH) activities. Based on these previous studies, we investigated the effects of three natural isoflavones, daidzin, daidzein, and genistein, on the modulation of the cocaine reinforcing effects and on cue-induced reinstatement in an operant mouse model of cocaine self-administration. Chronic treatment with daidzein or genistein decreased operant responding to obtain cocaine intravenous infusions. On the other hand, daidzein and daidzin, but not genistein, were effective in decreasing cue-induced cocaine reinstatement. Complementary studies revealed that daidzein effects on cocaine reinforcement were mediated through a mechanism that involved dopamine type-2/3 receptors (DA-D2/3) activities. Our results suggest that these natural compounds alone or in combination can be a potential therapeutic approach for cocaine addiction. Further clinical studies are required in order to ascertain their potential therapeutic use.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A male mouse model of WIN 55,212-2 self-administration to study cannabinoid addiction

  • Cajiao-Manrique, María del Mar
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
We have established for the first time a mouse model of cannabinoid addiction using WIN 55,212-2 intravenous self-administration (0.0125 mg/kg/infusion) in C57Bl/6J mice. This model allows to evaluate the addiction criteria by grouping them into 1) persistence of response during a period of non-availability of the drug, 2) motivation for WIN 55,212-2 with a progressive ratio, and 3) compulsivity when the reward is associated with a punishment such as an electric foot-shock, in agreement with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-5). This model also allows to measure two parameters that have been related with the DSM-5 diagnostic criteria of craving, resistance to extinction and reinstatement, and two phenotypic traits suggested as predisposing factors, impulsivity and sensitivity to reward. We found that 35.6% of mice developed the criteria of cannabinoid addiction, allowing to differentiate between resilient and vulnerable mice. Therefore, we have established a novel and reliable model to study the neurobiological correlates underlying the resilience or vulnerability to develop cannabinoid addiction. This model included the chemogenetic inhibition of neuronal activity in the medial prefrontal cortex to the nucleus accumbens pathway to assess the neurobiological substrate of cannabinoid addiction. This model will shed light on the neurobiological substrate underlying cannabinoid addiction.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model

  • Cajiao-Manrique, María del Mar
  • Casadó-Anguera, Verònica|||0000-0001-8532-2954
  • García-Blanco, Alejandra
  • Maldonado, Rafael|||0000-0002-4359-8773
  • Martín-García, Elena|||0000-0002-4487-3028
Cannabis addiction is a chronically relapsing disorder lacking effective treatment. Regular cannabis consumption typically begins during adolescence, and this early cannabinoid exposure may increase the risk for drug addiction in adulthood. This study investigates the development of cannabis addiction-like behavior in adult mice after adolescent exposure to the main psychoactive component of cannabis, Δ 9 -tetrahydrocannabinol (THC). Adolescent male mice were exposed to 5 mg/kg of THC from postnatal days 37 to 57. Operant self-administration sessions of WIN 55,212-2 (12.5 μg/kg/infusion) were conducted for 10 days. Mice were tested for three addiction-like criteria (persistence of response, motivation, and compulsivity), two parameters related to craving (resistance to extinction and drug-seeking behavior), and two phenotypic vulnerability traits related to substance use disorders (impulsivity and reward sensitivity). Additionally, qPCR assays were performed to detect differentially expressed genes in medial prefrontal cortex (mPFC), nucleus accumbens (NAc), dorsal striatum, and hippocampus (HPC) of "addicted" and "non-addicted" mice. Adolescent THC exposure did not modify WIN 55,212-2 reinforcement nor the development of cannabis addiction-like behavior. Inversely, THC pre-exposed mice displayed impulsive-like behavior in adulthood, which was more pronounced in mice that developed the addiction-like criteria. Moreover, downregulated drd2 and adora2a gene expression in NAc and HPC was revealed in THC pre-exposed mice, as well as a downregulation of drd2 expression in mPFC of vehicle pre-treated mice that developed addiction-like behaviors. These findings suggest that adolescent THC exposure may promote impulsivity-like behavior in adulthood, associated with downregulated drd2 and adora2a expression in NAc and HPC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Increased brain fractional perfusion in obesity using intravoxel incoherent motion (IVIM) MRI metrics

  • Motger Albertí, Anna|||0000-0002-9430-371X
  • de la Calle, Elena
  • Giménez, Mònica
  • Blasco, Gerard|||0000-0002-5302-0625
  • Biarnés, Carles|||0000-0002-6604-2014
  • Arnoriaga-Rodriguez, Maria|||0000-0002-0394-1223
  • Puig, Josep|||0000-0003-2791-6599
  • Coll-Martínez, Clàudia|||0000-0003-2927-4008
  • Contreras Rodríguez, Oren|||0000-0001-8922-8084
  • Fernández-Real Lemos, José Manuel|||0000-0002-7442-9323
Objective: This research seeks to shed light on the associations between brain perfusion, cognitive function, and mental health in individuals with and without obesity. Methods: In this study, we employed the noninvasive intravoxel incoherent motion (IVIM) magnetic resonance imaging (MRI) technique to examine brain fractional perfusion (FP) in two groups: individuals with obesity (N = 72) and healthy controls (N = 66). Additionally, we investigated potential associations between FP, cognitive function, and depressive symptoms in the participants with and without obesity. Finally, artificial intelligence algorithms (Boruta analysis) were also used. Results: Participants with obesity exhibited increased FP within dopaminergic brain circuits, particularly involving prefrontal cortex areas, anterior and posterior sections of the cingulate cortex, the right striatum, and the midbrain. Additionally, these individuals demonstrated lower working memory and higher depressive symptoms compared to the control group. Notably, higher FP in the inferior temporal and occipital cortices correlated with greater depressive symptoms, whereas increased FP in the right ventral caudate and the midbrain was associated with better working memory performance. A link between inflammatory and metabolic variables, with a particular emphasis on monocytes, and FP in obesity was also evidenced by Boruta analysis. Conclusions: Increased brain perfusion in individuals with obesity is associated with cognitive function and mental health through interaction with metabolic and inflammatory factors.